ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
Dow Jones
44.303,40
-0,99%
Euro vs US Dollar
1,03275
-0,04%
Bitcoin
96.027,95
-0,54%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE

  6. Hikma Pharmaceuticals Plc (HIK) Börsenkurse

Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc (HIK)

Haiki
Hikari Tsushin Inc
2.284,00
-10,00
(-0,44%)
Geschlossen 08 Februar 5:30PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
2.284,00
Gebot
2.280,00
Fragen
2.282,00
Volumen
358.585
2.280,00 Tagesbereich 2.296,00
1.750,00 52-Wochen-Bereich 2.302,00
Marktkapitalisierung
5,068B
Handelsende
2.294,00
Handelsbeginn
2.290,00
Letzte Trade
1310
@
2284
(O)
Letzter Handelszeitpunkt
Finanzvolumen
8.193.859p
VWAP
2.285,0534
Durchschnittliches Volumen (3 Mio.)
428.475
Ausgegebene Aktien
221.886.453
Dividendenrendite
4.29%
Kurs-Gewinn-Verhältnis
26,35
Gewinn pro Aktie (EPS)
0,87
Erlöse
2,88B
Nettogewinn
192M

Über Hikma Pharmaceuticals Plc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.hikma.com
Hauptsitz
London, Gbr
Gegründet
-
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker HIK. The last closing price for Hikma Pharmaceuticals was 2.294,00p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1.750,00p to 2.302,00p.

Hikma Pharmaceuticals currently has 221.886.453 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £5,09 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 26.35.

HIK Neueste Nachrichten

Weitere Nachrichten

Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg

Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg PR Newswire LONDON, Jan. 14, 2025 LONDON, Jan. 14, 2025 /PRNewswire/...

14 Januar 2025
PR Newswire (US)

Hikma Pharmaceuticals Plc Director/PDMR Shareholding

Hikma Pharmaceuticals Plc 23 December 2024   Hikma Pharmaceuticals PLC (the "Company") LONDON, 23 December 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) (LEI:...

23 Dezember 2024
RNS Regulatory News

Hikma Pharmaceuticals Plc Outcome of Audit Tender Process

Hikma Pharmaceuticals Plc 07 November 2024   Hikma Pharmaceuticals PLC Outcome of Audit Tender Process   LONDON, 7 November 2024 - Hikma Pharmaceuticals PLC ('the Company' or 'Hikma...

07 November 2024
RNS Regulatory News

Hikma Pharmaceuticals reiterates full-year guidance amid strong growth

Hikma Pharmaceuticals PLC on Thursday said it is on track to deliver "another strong performance" following trading t ...

07 November 2024
Alliance News

Hikma Pharmaceuticals Plc Trading Statement

Hikma Pharmaceuticals Plc 07 November 2024   Hikma continues strong strategic execution and reiterates guidance   London, 7 November 2024 - Hikma Pharmaceuticals PLC (Hikma, Group), the...

07 November 2024
RNS Regulatory News

Hikma Pharmaceuticals Plc 2024 Annual General Meeting Update Statement

Hikma Pharmaceuticals Plc 24 October 2024   Hikma Pharmaceuticals PLC 2024 Annual General Meeting Update Statement   LONDON, 24 October 2024 - Hikma Pharmaceuticals PLC ('Hikma' or 'the...

24 Oktober 2024
RNS Regulatory News

Hikma Pharmaceuticals Plc Block listing Interim Review

Hikma Pharmaceuticals Plc 01 October 2024   Hikma Pharmaceuticals PLC Block Listing Six Monthly Return   Date: 1 October 2024   Name of applicant: Hikma Pharmaceuticals PLC Name of scheme:...

01 Oktober 2024
RNS Regulatory News

Hikma Pharmaceuticals Plc Director/PDMR Shareholding

Hikma Pharmaceuticals Plc 24 September 2024   Hikma Pharmaceuticals PLC (the "Company")   LONDON, 24 September 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) (LEI:...

24 September 2024
RNS Regulatory News

Hikma Pharmaceuticals completes acquisition of Xellia's FDF business

Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form busine ...

10 September 2024
Alliance News
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1140.6167400881062270230222504869452287.14102625DE
423011.19766309642054230219865215722185.21456977DE
1249027.31326644371794230217834284752049.00284481DE
2645524.87698195741829230217574164311977.23120596DE
52358.518.61854063881925.5230217504187221942.52650562DE
15627013.4061569017201423021174.55694671785.98185784DE
26036418.9583333333192027661174.55986662027.82108829DE

HIK - Frequently Asked Questions (FAQ)

What is the current Hikma Pharmaceuticals share price?
The current share price of Hikma Pharmaceuticals is 2.284,00p
How many Hikma Pharmaceuticals shares are in issue?
Hikma Pharmaceuticals has 221.886.453 shares in issue
What is the market cap of Hikma Pharmaceuticals?
The market capitalisation of Hikma Pharmaceuticals is GBP 5,09B
What is the 1 year trading range for Hikma Pharmaceuticals share price?
Hikma Pharmaceuticals has traded in the range of 1.750,00p to 2.302,00p during the past year
What is the PE ratio of Hikma Pharmaceuticals?
The price to earnings ratio of Hikma Pharmaceuticals is 26,35
What is the cash to sales ratio of Hikma Pharmaceuticals?
The cash to sales ratio of Hikma Pharmaceuticals is 1,76
What is the reporting currency for Hikma Pharmaceuticals?
Hikma Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Hikma Pharmaceuticals?
The latest annual turnover of Hikma Pharmaceuticals is USD 2,88B
What is the latest annual profit for Hikma Pharmaceuticals?
The latest annual profit of Hikma Pharmaceuticals is USD 192M
What is the registered address of Hikma Pharmaceuticals?
The registered address for Hikma Pharmaceuticals is 1 NEW BURLINGTON PLACE, LONDON, W1S 2HR
What is the Hikma Pharmaceuticals website address?
The website address for Hikma Pharmaceuticals is www.hikma.com
Which industry sector does Hikma Pharmaceuticals operate in?
Hikma Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ASTAscent Resources Plc
1,90p
(100,00%)
591,55k
NTQEnteq Technologies Plc
2,85p
(58,33%)
17,97M
THRUThruvision Group Plc
3,25p
(30,00%)
307,66k
IMMImmupharma Plc
4,98p
(27,69%)
14,75M
GEXGeorgina Energy Plc
6,375p
(24,39%)
5,16M
BELLBelluscura Plc
1,875p
(-71,15%)
13,68M
APQApq Global Limited
2,00p
(-69,23%)
60,87k
IOMIomart Group Plc
45,40p
(-23,57%)
1,76M
SYMESupply@me Capital Plc
0,002p
(-20,00%)
736,23M
PRMProteome Sciences Plc
3,50p
(-17,45%)
50,06k
SYMESupply@me Capital Plc
0,002p
(-20,00%)
736,23M
ORCPOracle Power Plc
0,017p
(-14,14%)
523,64M
CPAICapai Plc
0,0475p
(7,95%)
355,25M
NTVONativo Resources Plc
0,0017p
(0,00%)
347,62M
MSMNMosman Oil And Gas Limited
0,04p
(2,56%)
263,67M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

LSE
HIK
Hikma Pharmaceuticals
AQSE
LAGR.GB
WisdomTree Commodity Sec...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten